Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-25-017747
Filing Date
2025-05-07
Accepted
2025-05-07 17:15:53
Documents
81
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ef20047548_10q.htm   iXBRL 10-Q 1008707
7 EXHIBIT 31.1 ef20047548_ex31-1.htm EX-31.1 9895
8 EXHIBIT 31.2 ef20047548_ex31-2.htm EX-31.2 9848
9 EXHIBIT 32.1 ef20047548_ex32-1.htm EX-32.1 4073
10 EXHIBIT 32.2 ef20047548_ex32-2.htm EX-32.2 4064
  Complete submission text file 0001140361-25-017747.txt   5858675

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA adma-20250331.xsd EX-101.SCH 51241
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE adma-20250331_def.xml EX-101.DEF 247385
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE adma-20250331_lab.xml EX-101.LAB 444444
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE adma-20250331_pre.xml EX-101.PRE 262605
6 INLINE XBRL TAXONOMY EXTENSION - CALCULATION LINKBASE DOCUMENT adma-20250331_cal.xml EX-101.CAL 39409
84 EXTRACTED XBRL INSTANCE DOCUMENT ef20047548_10q_htm.xml XML 718281
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36728 | Film No.: 25922735
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)